James Yang Liu's most recent trade in Oncocyte Corporation was a trade of 18,867 Restricted Stock Units done . Disclosure was reported to the exchange on March 26, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Oncocyte Corporation | James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 18,867 | 18,867 | - | - | Restricted Stock Units | |
Oncocyte Corporation | James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 10,000 | 10,000 | - | - | Option to Purchase Common Stock | |
Oncocyte Corporation | James Yang Liu | Sr Dir., Cntlr, PAO, Int PFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 10,000 | 10,000 | - | - | Option to Purchase Common Stock | |
Oncocyte Corporation | James Yang Liu | Controller, PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 57,065 | 57,065 | - | - | Option to Purchase Common Stock |